Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Lucentis BLA for wet AMD granted priority review

March 3, 2006

Recent patents disclose novel ophthalmic drugs

Feb. 28, 2006

DuoTrav eye drops recommended for approval in Europe

Feb. 27, 2006

Three-year follow-up shows Retisert improves visual acuity

Feb. 23, 2006

Positive preliminary phase IIb results for ecabet sodium in dry eye syndrome

Feb. 23, 2006

Santen updates status of ophthalmic programs

Feb. 16, 2006

Novartis Ophthalmics to copromote Retisert with Bausch & Lomb

Feb. 14, 2006

New data presented on PEDF gene therapy for age-related macular degeneration / News in Context

Feb. 13, 2006

High intake of antioxidants may reduce the risk of AMD

Feb. 7, 2006

Acuity studies Cand5 for wet AMD and diabetic macular edema

Feb. 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...